首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1485211

2024 年智慧 DDS（藥物傳輸系統）全球市場報告

Smart Drug Delivery Systems Global Market Report 2024

出版日期: 2024年05月21日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

智慧DDS（藥物傳輸系統）的市場規模預計在未來幾年將快速成長。 2028年，將以19.7%的複合年成長率成長至259.4億美元。預測期內的預期成長是由非傳染性疾病負擔增加、對精準醫療的日益關注、溫度測量的增加、對非侵入性給藥方法的需求不斷成長以及醫療保健支出的持續成長等因素推動的。由於多種因素。這段時期的主要趨勢包括小型化和微加工技術的進步、材料科學的創新、人工智慧（AI）和機器學習（ML）的整合、奈米藥物輸送系統的開發以及物聯網和穿戴式設備的整合。

慢性病盛行率的不斷上升將推動智慧 DDS（藥物傳輸系統）市場的成長。慢性病的特徵是長期的健康狀況，進展緩慢且原因複雜，並且由於老化、環境影響和獲得醫療保健方面的差異等因素而呈上升趨勢。智慧 DDS（藥物輸送系統）透過提高藥物療效和提高患者依從性，為慢性病管理提供了一個有前景的解決方案。例如，國家醫學圖書館的資料預測，到 2050 年，患有至少一種慢性病的人數將大幅增加，從而推動智慧 DDS（藥物輸送系統）市場的發展。

智慧 DDS（藥物輸送系統）市場的主要參與者專注於開發創新的可重複使用的藥物輸送設備，這將徹底改變藥物管理。其中之一是 Qfinity，這是一種可重複使用的藥物輸送裝置，設計用於皮下自我給藥。 Qfinity 可用於多次注射，而不是一次性使用，從而減少廢棄物並提供環境效益。例如，捷普公司於 2022 年 5 月推出了 Qfinity。該設備每台可進行 100 多次進樣，並與各種預填充藥筒相容。該設備不僅減少每次注射的碳排放，而且具有適應不同藥物體積和黏度的多功能性。此外，連網型版本 Qfinity+ 可以遠端監控患者照護以及內建感測器和電子設備的合規性，確保連接性而不影響易用性。

全球智慧DDS（藥物傳輸系統）市場：按產品分類的績效與預測，2018-2023、2023-2028F、2033F
連接吸入器
連接自動注射器
連接筆式注射器
連接的穿戴式注射器
附加元件感測器
其他產品
全球智慧DDS（藥物傳遞系統）市場：依治療領域分類的表現與預測，2018-2023、2023-2028F、2033F
代謝紊亂
神經系統疾病
呼吸系統疾病
荷爾蒙失調
其他治療領域
全球智慧DDS（藥物傳遞系統）市場：按藥物傳輸模式分類的實際和預測，2018-2023、2023-2028F、2033F
注射
吸入
口服
全球智慧DDS（藥物傳輸系統）市場：最終用戶的表現與預測，2018-2023、2023-2028F、2033F
醫院
診所
居家照護
門診就診環境
其他最終用戶

第 7 章區域/國家分析

全球智慧DDS（藥物傳輸系統）市場：按地區分類的績效與預測，2018-2023、2023-2028F、2033F
全球智慧DDS（藥物傳輸系統）市場：按國家分類的績效與預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭格局及公司概況

智慧DDS（藥物傳輸系統）市場：競爭格局
智慧 DDS（藥物傳輸系統）市場：公司簡介
- Pfizer Inc
- Johnson & Johnson
- Bayer AG
- Abbott Laboratories
- Novartis International AG

第31章其他重大及創新企業

Medtronic plc
Eli Lilly and Company
Amgen Inc
Novo Nordisk
Merck Group
Becton Dickinson and Company
Stryker Corporation
Baxter International Inc
Boston Scientific Corporation
Biogen Inc
Vertex Pharmaceuticals Incorporated
Phillips-Medisize Corporation
ResMed Inc.
West Pharmaceutical Services Inc
Insulet Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄

Product Code: r17438

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $10.61 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for drug delivery systems, rising patient compliance with treatment regimens, the growing prevalence of chronic diseases, the rise of personalized medicine approaches, and the need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.7%. The anticipated growth in the forecast period can be attributed to several factors, including the growing burden of non-communicable diseases, an increased focus on precision medicine, the rise of theragnostics, a growing demand for non-invasive drug delivery methods, and the continual increase in healthcare expenditure. Major trends expected during this period include advancements in miniaturization and microfabrication technologies, innovations in material science, the integration of artificial intelligence (AI) and machine learning (ML), the development of nano-sized drug delivery systems, and the integration of IoT and wearable technology into drug delivery systems.

The increasing prevalence of chronic diseases is poised to drive the growth of the smart drug delivery systems market. Chronic diseases, characterized by long-term health conditions with slow progression and complex causes, are on the rise due to factors such as aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising solution for managing chronic diseases by enhancing medication effectiveness and improving patient adherence. For example, data from the National Library of Medicine forecasts a substantial increase in the number of individuals with at least one chronic illness by 2050, underscoring the significant role of rising chronic disease prevalence in propelling the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc, Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc, Boston Scientific Corporation, Biogen Inc, Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Including: 1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors
2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders
3) By Drug Delivery Mode: Injectable; Inhalation; Oral
4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings
Covering: Pfizer Inc.; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Smart Drug Delivery Systems Market Size and Growth

5.1. Global Smart Drug Delivery Systems Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Drug Delivery Systems Market Segmentation

6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Connected Inhalers
Connected Autoinjectors
Connected Pen Injectors
Connected Wearable Injectors
Add-On Sensors
Other Products
6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Metabolic Disorders
Neurological Disorders
Respiratory Disorders
Hormonal Disorders
Other Therapeutic Areas
6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Injectable
Inhalation
Oral
6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Home Care
Ambulatory Care Settings
Other End-Users

7. Smart Drug Delivery Systems Market Regional And Country Analysis

7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Drug Delivery Systems Market

9.1. China Smart Drug Delivery Systems Market Overview
9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Drug Delivery Systems Market

10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Drug Delivery Systems Market

11.1. Japan Smart Drug Delivery Systems Market Overview
11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Drug Delivery Systems Market

12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

14.1. South Korea Smart Drug Delivery Systems Market Overview
14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

15.1. Western Europe Smart Drug Delivery Systems Market Overview
15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Drug Delivery Systems Market

16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Drug Delivery Systems Market

17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Drug Delivery Systems Market

18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Drug Delivery Systems Market

19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Drug Delivery Systems Market

20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Drug Delivery Systems Market

22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Drug Delivery Systems Market

23.1. North America Smart Drug Delivery Systems Market Overview
23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Drug Delivery Systems Market

24.1. USA Smart Drug Delivery Systems Market Overview
24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Drug Delivery Systems Market

25.1. Canada Smart Drug Delivery Systems Market Overview
25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Drug Delivery Systems Market

26.1. South America Smart Drug Delivery Systems Market Overview
26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

28.1. Middle East Smart Drug Delivery Systems Market Overview
28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Drug Delivery Systems Market

29.1. Africa Smart Drug Delivery Systems Market Overview
29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

30.1. Smart Drug Delivery Systems Market Competitive Landscape
30.2. Smart Drug Delivery Systems Market Company Profiles
- 30.2.1. Pfizer Inc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis International AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

31.1. Medtronic plc
31.2. Eli Lilly and Company
31.3. Amgen Inc
31.4. Novo Nordisk
31.5. Merck Group
31.6. Becton Dickinson and Company
31.7. Stryker Corporation
31.8. Baxter International Inc
31.9. Boston Scientific Corporation
31.10. Biogen Inc
31.11. Vertex Pharmaceuticals Incorporated
31.12. Phillips-Medisize Corporation
31.13. ResMed Inc.
31.14. West Pharmaceutical Services Inc
31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking

33. Global Smart Drug Delivery Systems Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market Future Outlook and Potential Analysis

35.1 Smart Drug Delivery Systems Market In 2028 - Countries Offering Most New Opportunities
35.2 Smart Drug Delivery Systems Market In 2028 - Segments Offering Most New Opportunities
35.3 Smart Drug Delivery Systems Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies